HURA TuHURA Biosciences, Inc.
Healthcare$2.45-2.00%ClosedMarket Cap: $156.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
6.47
P/S
0.00
EV/EBITDA
-5.08
DCF Value
$0.07
FCF Yield
-17.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-154.0%
ROA
-104.1%
ROIC
-135.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-7.5M | $-7.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-8.2M | $-6.8M | $— | — |
| FY null | $0.00 | NaN% | $-31.8M | $-30.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-6.7M | $-7.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-9.9M | $-9.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.0M | $-6.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-5.7M | $-6.0M | $— | — |
| FY null | $0.00 | NaN% | $-17.6M | $-21.7M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-3.7M | $-5.6M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-2.4M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.6M | $-4.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-1.0M | $-1.0M | $-8.27 | — |